| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0038 | 1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.005 | 1 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |